Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
Pre-publication versions of this article are available by contacting email@example.com.
|7 Feb 2017||Submitted||Original manuscript|
|15 Mar 2017||Reviewed||Reviewer Report - Limin Wang|
|21 Mar 2017||Reviewed||Reviewer Report - Shanmugam Panneer Selvam|
|15 Apr 2017||Author responded||Author comments - Haidan Liu|
|Resubmission - Version 2|
|15 Apr 2017||Submitted||Manuscript version 2|
|25 Apr 2017||Reviewed||Reviewer Report - Limin Wang|
|31 May 2017||Author responded||Author comments - Haidan Liu|
|Resubmission - Version 3|
|31 May 2017||Submitted||Manuscript version 3|
|22 Jun 2017||Editorially accepted|
|28 Jun 2017||Article published||10.1186/s12885-017-3442-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.